Stroom became interesting because the pitch turned into a competitive process in FMCG / Health Snacks. The founders walked in with an opening ask of ₹1 Crore for 2%, but the bigger signal was that multiple sharks felt there was enough upside to split the deal rather than let one investor take it alone.
Why this company got a hearing
The room was not buying a story alone; it was deciding whether the operating case behind the story held up.
Stroom attempts to mainstream protein consumption in India by blending milk and soy protein into familiar, highly palatable formats like chocolate wafers and chewy bars, bypassing the chalky taste of traditional whey isolates.
How the deal reshaped the math
The room ultimately priced the company below the founders' opening frame. An ask built around ₹50 Cr moved to ₹40 Cr, which means the investors were willing to engage, but only after marking down the assumptions driving the original number.
The negotiation math matters because valuation is where optimism collides with investor risk tolerance.
The room marked the business down from ₹50 Cr to ₹40 Cr, a 20% reset. That usually means investor interest survived, but only after discounting the founders’ original assumptions.
Final terms: ₹1 Cr for 2.5% + 2% Advisory.
Equity on the table matters too. At 2%, the founders were trading ownership for speed, validation, and access, not just the cheque itself.
The founders asked for a ₹50 Crore valuation, backed by strong ₹2.42 Crore net sales and quick-commerce traction. After a tough negotiation regarding packaging ethics and taste profiles, they settled for a ₹40 Crore valuation, conceding an extra 0.5% in standard equity and 2% in advisory equity to lock in two Sharks.
Where the leverage moved
The room moved because two investors saw different forms of upside in the same company. That usually means the founders did enough to make the opportunity legible from more than one angle: brand, distribution, category timing, or operator execution.
Negotiation matters here because investor behavior often reveals more than the final headline ever does.
A two-investor outcome often suggests the business made sense from more than one angle. One shark may have liked category or brand, while another saw operational or distribution upside.
Investors involved: Vineeta Singh, Kunal Bahl.
Shark Viraj Bahl aggressively attacked the brand's 'no refined sugar' labeling, pointing out that their ingredient list included honey and cookie bits (which contain sugar). Additionally, Varun Alagh openly rejected the taste of their coffee-almond bar. The founders had to swallow their pride, admit the packaging error, and pivot the conversation back to their stellar sales data to save the pitch.
What we would watch next
Invest does not mean the founders "won" the market. It means the room found enough evidence to back the company on negotiated terms. The next question is whether Stroom can turn that room-level conviction into durable execution after the cameras stop rolling.
A useful verdict should help another founder sharpen their next room, not just react to this one.
INVEST. Stroom did not “win” the market by getting a cheque. The room simply found enough evidence to back the company on negotiated terms, and execution now has to justify that confidence outside the studio.
- When more than one investor wants in, founders often protect value by slowing the close, not rushing it.
- The strongest lesson is usually not the pitch theatre, but how clearly the founders defended the business when challenged.
- Matching the ask is usually a sign that the founders kept the room anchored to their own frame instead of getting dragged into defensive math.
- When more than one shark wants in, the founders usually win by protecting optionality and resisting the urge to rush the first acceptable term sheet.
- In FMCG / Health Snacks, category excitement alone is rarely enough. Investors still want evidence that the business can scale without the story collapsing under margin, trust, or repeatability pressure.